Onsemi Authorizes $6 Bln Share Repurchase Program Over Three Years

onsemi's board approved a new $6 billion share repurchase program effective Jan. 1, 2026 through Dec. 31, 2028, following the expiration of a prior $3 billion authorization on Dec. 31, 2025; under the prior plan the company repurchased $2.1 billion of stock over three years and spent roughly 100% of 2025 free cash flow on buybacks. The company said repurchases may occur in the open market, via private transactions or other means, and the authorization can be suspended and does not obligate repurchases. The enlarged buyback program signals a continued focus on shareholder returns and should be supportive of EPS and equity valuation, but comes after a year in which buybacks consumed nearly all free cash flow, a factor investors should weigh against reinvestment and liquidity considerations.

Analysis

onsemi's board authorized a new $6.0 billion share repurchase program covering Jan. 1, 2026 through Dec. 31, 2028, to follow the prior $3.0 billion authorization that expires Dec. 31, 2025. Under the previous plan the company repurchased $2.1 billion over three years and spent approximately 100% of 2025 free cash flow on buybacks, indicating heavy use of cash for capital returns. The new authorization permits open-market and privately negotiated transactions, may be suspended at management's discretion and does not obligate any purchases, so actual execution and timing will determine near-term market effect. The program is moderately positive for EPS and valuation if executed, but the prior-year consumption of FCF raises questions about funding sources, balance-sheet flexibility and potential crowding out of reinvestment that investors should monitor closely.

Investors should note the repurchase program does not commence until 2026, so any immediate market reaction will reflect expectations rather than cash deployment; realized impact depends on repurchase pacing and actual reductions in share count. Key metrics to watch include 2026 free cash flow generation, leverage and liquidity metrics, commentary on whether repurchases will be funded from FCF or other means, and any disclosures on trade-offs with capex or R&D. Given the authorization's size relative to prior repurchases, governance and execution transparency will be important to assess whether buybacks are value-accretive versus being a tool to support near-term EPS.

Key Decisions for Investors

• Consider maintaining or modestly increasing exposure if management demonstrates sustainable 2026 free cash flow generation to fund the program; require confirmation of improving FCF before materially adding to positions
• Monitor funding and balance-sheet indicators closely—if repurchases are likely to be debt-funded or to materially reduce capex/R&D, reduce exposure or demand clearer capital-allocation priorities
• Track actual repurchase activity after Jan. 1, 2026 and any suspension notices; use price weakness as an opportunity to add incrementally only if repurchases are executed and FCF trends remain healthy
• Implement position sizing limits or hedges given that buybacks consumed ~100% of 2025 FCF, and reassess if capital allocation shifts away from investments that drive long-term growth